Flonase Nasal Spray

Company
GlaxoSmithKline

Approval Status
Approved November 1997

Treatment for
allergic rhinitis

Areas
Immune System , Respiratory

Flonase nasal spray has been approved by the FDA for the treatment of seasonal and perennial allergic rhintis in children four years and older. This supplementary new dosage application represents an extension of the product to include younger children.

Flonase_nasal_spray Drug Information

The Flonase_nasal_spray drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top